JLL Partners announced an investment in Nashua, New Hampshire-based Vascular Technology (VTI).
VTI is a medical device company specializing in the development, manufacture, and sale of surgical devices, including Intraoperative Doppler Systems and Surgical Suction Irrigation Systems. The company provides products that are utilized across multiple surgical specialties, including vascular, reconstructive, urology, GI endoscopy, neuro and robotic surgery. VTI is ISO 13485 certified and FDA registered.
JLL Partners is a middle-market private equity firm based in New York, New York. Since its founding in 1988, JLL Partners has committed approximately $8 billion of equity capital across nine private equity funds, with 60 platform investments and 183 add-on acquisitions.
Through this transaction, JLL partnered with entrepreneur Nilendu Srivastava, and the rest of the VTI management team, to execute a shared vision of accelerating VTI’s growth and expanding its product portfolio. JLL announced the appointment of Greg Groenke as VTI’s Chief Executive Officer and Lars Marcher as its Executive Chairman.
Upon joining VTI, Greg Groenke said, “I am thrilled to join VTI at this exciting juncture. VTI has an exceptional history of innovation, and I look forward to working alongside our talented team to further advance our technologies, broaden our market reach, and continue delivering critical surgical tools that improve patient outcomes.”
Lars Marcher said, “Today’s medtech landscape requires companies and teams to innovate boldly. VTI has already built a strong foundation, and I’m committed to strengthening its global trajectory by energizing our people, enhancing our offerings, and delivering real impact to our customers and the communities they serve.”
MedWorld Advisors served as the financial advisor to VTI, and Moelis & Company served as the financial advisor to JLL. Financial terms of the deal were not disclosed.
According to data captured in the LevinPro HC database, this marks the 44th Medical Device transaction of 2025. There were 87 Medical Device deals announced during 2024, 112 announced in 2023 and 124 announced during 2022.
